"10.1371_journal.pone.0141688","plos one","2015-11-04T00:00:00Z","Marta Winiecka-Klimek; Maciej Smolarz; Maciej P Walczak; Jolanta Zieba; Krystyna Hulas-Bigoszewska; Blazej Kmieciak; Sylwester Piaskowski; Piotr Rieske; Dawid P Grzela; Ewelina Stoczynska-Fidelus","Department of Research and Development, Celther Polska, Lodz, Poland; Department of Tumor Biology, Medical University of Lodz, Lodz, Poland; Department of Medical Law, Chair of Human Sciences, Medical University of Lodz, Lodz, Poland","Conceived and designed the experiments: MWK PR ESF. Performed the experiments: MWK MS DPG MPW JZ KHB. Analyzed the data: MWK MS DPG MPW JZ KHB BK SP PR ESF. Contributed reagents/materials/analysis tools: PR EFS SP DPG. Wrote the paper: MWK PR ESF DPG. Revised manuscript critically for important intellectual content: DPG BK. Performed bioethics analysis associated with the use of hESC-derived NSC cells: BK. Performed statistical analysis: MWK. Participated in acquisition of funding: SP PR ESF.","Grzela DP, Piaskowski S, Rieske P, and Stoczynska-Fidelus E have submitted a patent application on this technology (The INS cells and the method for reprogramming somatic cells to INS cells using Sox2 or Sox2 and c-Myc EP13001847). This does not alter their adherence to all the PLOS ONE policies on sharing data and materials. The authors have declared that no other competing interests exist.","2015","11","Marta Winiecka-Klimek","MWK",10,TRUE,3,6,10,4,TRUE,TRUE,FALSE,0,NA,FALSE
